Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Studies Highlight Risk of Damage from Lupus Treatments

Mary Beth Nierengarten  |  Issue: April 2017  |  April 20, 2017

Compared with whites, blacks died from SLE at a younger age, with 50% of total deaths in blacks occurring by age 45 compared with age 59 in whites. Hispanics also died younger, with 50% of deaths occurring by age 44 compared with age 54 for non-Hispanics.

“These data on secular trends and disparities call to action the need to develop targeted research and public health programs to identify the modifiable risk factors in order to promote health equity among patients of all backgrounds with SLE,” said Dr. Singh.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Mary Beth Nierengarten is a freelance medical journalist based in Minneapolis.

References

  1. Little J, Lunt M, Parker B, Bruce IN. Total and glucocorticoid-related damage accrual in the systemic lupus international collaborating clinics inception cohort [abstract 3167]. Arthritis Rheumatol. 2016;68(suppl 10).
  2. Jorge A, Lu N, Rai SK, Choi H. Mortality trends in systemic lupus erythematosus: A general population-based cohort study [abstract 3169]. Arthritis Rheumatol. 2016;68(suppl 10).
  3. Yen E, Shaheen M, Woo JM, et al. Temporal trends in SLE mortality according to sex, race, ethnicity, and geographic region in the United States over the past five decades [abstract 3172]. Arthritis Rheumatol. 2016;68(suppl 10).

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsResearch RheumSystemic Lupus Erythematosus Tagged with:2016 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)damageglucocorticoidLupusmorbiditymortalitypatient careResearchrheumatologySLEtherapyTreatment

Related Articles

    A Heart In Danger

    November 1, 2006

    Rheumatologists should monitor and aggressively treat cardiac risk factors in patients with lupus and rheumatoid arthritis

    Lupus often presents with a butterfly rash.

    Top 12: Research in Systemic Lupus Erythematosus at a Glance

    November 18, 2021

    Dr. Pisetsky’s picks for the top research in lupus presented at ACR Convergence 2021.

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences